Clarus Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clarus Therapeutics, Inc..The latest application filed is for "methods of treating testosterone deficiency".

Company Profile

19.21.40

Clarus Therapeutics, Inc. - Northbrook IL US
Clarus Therapeutics, Inc. - Nothbrook IL
Clarus Therapeutics Inc - Northbrook IL
Clarus Therapeutics, Inc. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same Grant 11,426,416 - Dudley , et al. August 30, 2	2022-08-30
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same Grant 11,331,325 - Dudley , et al. May 17, 2	2022-05-17
Methods Of Treating Testosterone Deficiency App 20220088034 - DUDLEY; Robert E. ; et al.	2022-03-24
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same Grant 11,179,402 - Dudley , et al. November 23, 2	2021-11-23
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same Grant 11,179,403 - Dudley , et al. November 23, 2	2021-11-23
Methods Of Treating Testosterone Deficiency App 20210220374 - DUDLEY; Robert E. ; et al.	2021-07-22
Methods Of Treating Testosterone Deficiency App 20200323880 - DUDLEY; Robert E. ; et al.	2020-10-15
Methods Of Treating Testosterone Deficiency App 20200197413 - DUDLEY; Robert E. ; et al.	2020-06-25
Methods Of Treating Testosterone Deficiency App 20200197412 - DUDLEY; Robert E. ; et al.	2020-06-25
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same Grant 10,617,696 - Dudley , et al.	2020-04-14
Oral Testosterone Ester Formulations And Methods Of Treating Testosterone Deficiency Comprising Same App 20200093836 - DUDLEY; Robert E. ; et al.	2020-03-26
Methods Of Treating Testosterone Deficiency App 20200054648 - DUDLEY; Robert E. ; et al.	2020-02-20
Oral Testosterone Ester Formulations And Methods Of Treating Testosterone Deficiency Comprising Same App 20200046732 - DUDLEY; Robert E. ; et al.	2020-02-13
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20200046733 - DUDLEY; Robert E. ; et al.	2020-02-13
Methods Of Treating Testosterone Deficiency App 20200038411 - DUDLEY; Robert E. ; et al.	2020-02-06
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same Grant 10,543,219 - Dudley , et al. Ja	2020-01-28
Oral Pharmaceutical Products And Methods Of Use Combining Testosterone Esters With Hypolipidemic Agents App 20200016172 - SALAMEH; Wael ; et al.	2020-01-16
Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents Grant 10,245,273 - Salameh , et al.	2019-04-02
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20190070196 - DUDLEY; Robert E. ; et al.	2019-03-07
Methods Of Treating Testosterone Deficiency App 20180333423 - DUDLEY; Robert E. ; et al.	2018-11-22
Oral Testosterone Ester Formulations And Methods Of Treating Testosterone Deficiency Comprising Same App 20180110786 - DUDLEY; Robert E. ; et al.	2018-04-26
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20180078566 - DUDLEY; Robert E. ; et al.	2018-03-22
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20180071311 - DUDLEY; Robert E. ; et al.	2018-03-15
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20180028542 - DUDLEY; Robert E. ; et al.	2018-02-01
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20180021351 - DUDLEY; Robert E. ; et al.	2018-01-25
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20180021350 - DUDLEY; Robert E. ; et al.	2018-01-25
Methods Of Treating Testosterone Deficiency App 20170246184 - DUDLEY; Robert E. ; et al.	2017-08-31
Oral Testosterone Ester Formulations And Methods Of Treating Testosterone Deficiency Comprising Same App 20170106002 - DUDLEY; Robert E. ; et al.	2017-04-20
Oral Pharmaceutical Products And Methods Of Use Combining Testosterone Esters With Hypolipidemic Agents App 20160317553 - Salameh; Wael ; et al.	2016-11-03
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20160000806 - Dudley; Robert E. ; et al.	2016-01-07
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20150343074 - Dudley; Robert E. ; et al.	2015-12-03
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20150343073 - Dudley; Robert E. ; et al.	2015-12-03
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20150343072 - Dudley; Robert E. ; et al.	2015-12-03
Methods Of Treating Testosterone Deficiency App 20140303129 - Dudley; Robert E. ; et al.	2014-10-09
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Compositions Comprising Same App 20140296199 - Dudley; Robert E. ; et al.	2014-10-02
Oral Testosterone Ester Formulations And Methods Of Treating Testosterone Deficiency Comprising Same App 20140274986 - Dudley; Robert E. ; et al.	2014-09-18
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same Grant 8,828,428 - Dudley , et al. September 9, 2	2014-09-09
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20140249124 - Dudley; Robert E. ; et al.	2014-09-04
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same Grant 8,778,917 - Dudley , et al. July 15, 2	2014-07-15
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same Grant 8,778,916 - Dudley , et al. July 15, 2	2014-07-15
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Compositions Comprising Same App 20140011789 - Dudley; Robert E. ; et al.	2014-01-09
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same Grant 8,492,369 - Dudley , et al. July 23, 2	2013-07-23
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same App 20130022674 - Dudley; Robert E. ; et al.	2013-01-24
Oral Testosterone Ester Formulations And Methods Of Treating Testosterone Deficiency Comprising Same App 20120309731 - Dudley; Robert E. ; et al.	2012-12-06
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same Grant 8,241,664 - Dudley , et al. August 14, 2	2012-08-14
Oral Testosterone Ester Formulations And Methods Of Treating Testosterone Deficiency Comprising Same App 20110251167 - Dudley; Robert E. ; et al.	2011-10-13
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Compositions Comprising Same App 20080317844 - Dudley; Robert E. ; et al.	2008-12-25

Company Registrations

NCAGE Code	8GCE8	CLARUS THERAPEUTICS, INC.
CAGE Code	8GCE8	CLARUS THERAPEUTICS, INC.
S.A.M. Registration	8GCE8 [556777469]	CLARUS THERAPEUTICS, INC.
SEC	0001286162	CLARUS THERAPEUTICS INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.